Ligand Binding Prediction Using Protein Structure Graphs and Residual Graph Attention Networks
Open Access
Abstract
Computational prediction of ligand–target interactions is a crucial part of modern drug discovery as it helps to bypass high costs and labor demands of in vitro and in vivo screening. As the wealth of bioactivity data accumulates, it provides opportunities for the development of deep learning (DL) models with increasing predictive powers. Conventionally, such models were either limited to the use of very simplified representations of proteins or ineffective voxelization of their 3D structures. Herein, we present the development of the PSG-BAR (Protein Structure Graph-Binding Affinity Regression) approach that utilizes 3D structural information of the proteins along with 2D graph representations of ligands. The method also introduces attention scores to selectively weight protein regions that are most important for ligand binding. Results: The developed approach demonstrates the state-of-the-art performance on several binding affinity benchmarking datasets. The attention-based pooling of protein graphs enables identification of surface residues as critical residues for protein–ligand binding. Finally, we validate our model predictions against an experimental assay on a viral main protease (Mpro)—the hallmark target of SARS-CoV-2 coronavirus.Keywords
All Related Versions
Funding Information
- Canadian Institutes of Health Research (AWD-015014)
- TELUS, Teck Resources, 625 Powell Street Foundation, Tai Hung Fai Charitable Foundation, Vancouver General Hospital Foundation
This publication has 60 references indexed in Scilit:
- Hit Identification and Optimization in Virtual Screening: Practical Recommendations Based on a Critical Literature AnalysisJournal of Medicinal Chemistry, 2013
- Comprehensive analysis of kinase inhibitor selectivityNature Biotechnology, 2011
- CSAR Benchmark Exercise of 2010: Selection of the Protein–Ligand ComplexesJournal of Chemical Information and Modeling, 2011
- How to improve R&D productivity: the pharmaceutical industry's grand challengeNature Reviews Drug Discovery, 2010
- The RCSB PDB information portal for structural genomicsNucleic Acids Research, 2006
- Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main ProteasesPLOS Biology, 2005
- The PDBbind Database: Methodologies and UpdatesJournal of Medicinal Chemistry, 2005
- Successful in Silico Discovery of Novel Nonsteroidal Ligands for Human Sex Hormone Binding GlobulinJournal of Medicinal Chemistry, 2005
- Inductive QSAR Descriptors. Distinguishing Compounds with Antibacterial Activity by Artificial Neural NetworksInternational Journal of Molecular Sciences, 2005
- Long-Range Attraction and Molecular Rearrangements in Receptor-Ligand InteractionsScience, 1992